Endologix Net Worth 2010-2020 | ELGXQ
Interactive chart of historical net worth (market cap) for Endologix (ELGXQ) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Endologix net worth as of April 25, 2025 is $0B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.000B | $0.000B |
| Endologix, Inc. develops, manufactures and markets products for the treatment of coronary and vascular diseases. A leader in the emerging field of vascular brachytherapy, Endologix, has developed a unique method for the delivery of radiation to prevent restenosis following the interventional treatment of atherosclerosis. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $87.363B | 23.91 |
| Becton Dickinson (BDX) | United States | $57.057B | 14.28 |
| Cardinal Health (CAH) | United States | $32.542B | 17.43 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.704B | 0.00 |
| Labcorp (LH) | United States | $18.166B | 14.90 |
| Cooper (COO) | United States | $15.901B | 21.09 |
| West Pharmaceutical Services (WST) | United States | $14.596B | 29.91 |
| Align Technology (ALGN) | United States | $12.549B | 24.31 |
| Henry Schein (HSIC) | United States | $7.930B | 13.66 |
| Merit Medical Systems (MMSI) | United States | $5.369B | 26.12 |
| Patterson (PDCO) | United States | $2.772B | 15.98 |
| DENTSPLY SIRONA (XRAY) | United States | $2.557B | 7.68 |
| CONMED (CNMD) | United States | $1.503B | 11.68 |
| STAAR Surgical (STAA) | United States | $0.833B | 0.00 |
| Pro-Dex (PDEX) | United States | $0.198B | 30.26 |
| Lifevantage (LFVN) | United States | $0.169B | 18.65 |